Cargando…
Risk Assessment in Drug Hypersensitivity: Detecting Small Molecules Which Outsmart the Immune System
Drug hypersensitivity (DH) reactions are clinically unusual because the underlying immune stimulations are not antigen-driven, but due to non-covalent drug-protein binding. The drugs may bind to immune receptors like HLA or TCR which elicits a strong T cell reaction (p-i concept), the binding may en...
Autores principales: | Pichler, Werner J., Watkins, Stephen, Yerly, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974731/ https://www.ncbi.nlm.nih.gov/pubmed/35386664 http://dx.doi.org/10.3389/falgy.2022.827893 |
Ejemplares similares
-
The Activation Pattern of Drug-Reacting T Cells Has an Impact on the Clinical Picture of Hypersensitivity Reactions
por: Wuillemin, Natascha, et al.
Publicado: (2022) -
Cofactors of drug hypersensitivity—A monocenter retrospective analysis
por: Kühl, Johanna, et al.
Publicado: (2023) -
Assessing delayed penicillin hypersensitivity using the PENFAST+ score
por: Castagna, Julie, et al.
Publicado: (2023) -
Use of Rapid Drug Desensitization in Delayed Hypersensitivity Reactions to Chemotherapy and Monoclonal Antibodies
por: Vega, Arantza, et al.
Publicado: (2022) -
Hypersensitivity to intravenous succinate corticosteroids in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease
por: Taniguchi, Masami, et al.
Publicado: (2023)